NRC Health (NRC)

Stock NASDAQ

$23.83

+0.34 (+1.45%)

Delayed quote.

Price history

Daily close
NRC daily closing price, Nov 3, 2025 to Oct 30, 2026 Closed at $13.25 on Nov 3, 2025 and $23.83 on Oct 30, 2026, a change of +79.85%. Range $12.03 to $23.83.
Daily closes, Nov 3, 2025 to Oct 30, 2026 (250 trading days).
Start
$13.25
Latest close
$23.83
Period change
+79.85%
Period low
$12.03
Period high
$23.83

Key metrics

Market cap
$527.11M
Volume
86.2K
Average volume
110.0K
52-week range
$11.73 – $24.40
Beta
0.38
Last dividend
$0.60
EPS (TTM)
$0.30
P/E ratio
78.78
Revenue (TTM)
$143.79M
Net income (TTM)
$6.44M
Total assets
$139.21M
Total debt
$102.90M
Cash and equivalents
$3.63M

Key financials (trailing twelve months).

Company profile

National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
CEO
Trent Green
Employees
357
Headquarters
Lincoln, NE, US
IPO date
2013-05-23

Financial statements

Annual, last 3 fiscal years. Most recent period first. Reported in USD.

Income statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Revenue$137.39M$143.06M$148.58M
Gross profit$77.39M$86.13M$92.56M
Operating income$22.59M$35.19M$40.05M
EBITDA$30.23M$41.31M$45.98M
Net income$11.60M$24.78M$30.97M
Diluted EPS$0.52$1.04$1.25
Balance sheet
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Cash and equivalents$4.14M$4.23M$6.65M
Total assets$134.88M$132.54M$122.44M
Total liabilities$120.89M$101.25M$73.48M
Total debt$79.03M$64.41M$38.96M
Shareholders’ equity$13.99M$31.28M$48.95M
Cash flow statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Operating cash flow$26.45M$34.62M$38.11M
Capital expenditure-$10.71M-$15.45M-$15.78M
Free cash flow$15.74M$19.18M$22.33M

Quarterly, last 6 quarters. Most recent period first. Reported in USD.

Income statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Revenue$38.40M$35.39M$34.80M$35.19M$34.61M$34.04M
Gross profit$8.91M$21.83M$18.99M$19.11M$20.01M$19.32M
Operating income$8.91M-$3.24M$5.57M$4.67M$7.74M$1.59M
EBITDA$11.00M-$1.09M$7.80M$6.78M$9.93M$3.35M
Net income$4.70M-$3.28M$3.22M$1.80M$4.12M-$106.0K
Diluted EPS$0.21-$0.15$0.14$0.08$0.18$0.00
Balance sheet
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Cash and equivalents$3.63M$3.33M$2.55M$4.14M$2.22M$5.27M
Total assets$139.21M$136.15M$134.56M$134.88M$135.72M$141.39M
Total liabilities$148.34M$129.60M$121.06M$120.89M$121.41M$120.06M
Total debt$102.90M$90.03M$78.03M$79.03M$80.04M$80.96M
Shareholders’ equity-$9.12M$6.55M$13.49M$13.99M$14.31M$21.33M
Cash flow statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Operating cash flow$8.02M$1.39M$7.18M$7.18M$13.76M-$1.14M
Capital expenditure-$1.04M-$1.32M-$1.83M-$1.12M-$3.59M-$3.01M
Free cash flow$6.98M$62.0K$5.35M$6.06M$10.18M-$4.15M